Drugs / GCSF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04514692 | Feb 2021 → Sep 2023 | cervical cancer, endometrial cancer | Stanford University | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04514692 ↗ |
| Modality | Protein / enzyme biologic | “G-CSF is a type of growth factor. Growth factors are proteins made in the body.” NCT04514692 ↗ |